Microarrays allow researchers to better understand the relationship between gene expression and physiological function. Thanks to many recent technology and bioinformatics advances, clinicians are ...

Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...

New York, USA, May 06, 2026 (GLOBE NEWSWIRE)-- Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight The DNA microarray market is witnessing ...

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering. This report is an analysis of ...

Microarray technologies are widely used in drug discovery to determine and develop drug molecules in a short duration with high specificity. Severe chronic diseases such as cancer, mental illness, ...

Dublin, Oct. 12, 2017 (GLOBE NEWSWIRE) -- The "Biochips and Microarrays - Technologies, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering. This ...

Ariosa Diagnostics announced that its scientists have successfully tested and implemented a microarray DNA quantification method for Ariosa's Harmony Non-Invasive Prenatal Test SAN JOSE, California, ...

The alternative text for this image may have been generated using AI. High-throughput genome screening technologies, such as cDNA microarrays, have made it possible to survey 5,000–50,000 genes in a ...

Arrayjet, the Scottish-based microarray instrumentation company, has secured a GBP250,000 contract to provide the Swedish SciLifeLab - the national hub for molecular bioscience in Sweden - with ...

Microarray technology could be used to tailor therapy according to the individual, and prevent breast cancer patients from having to undergo painful unsuccessful therapies. In a study published in the ...

Mutant alleles of dominant, highly penetrant breast cancer genes, including BRCA1 and BRCA2, do not occur frequently, and hence account for only a small proportion of breast cancer cases. On the other ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of Jain PharmaBiotech's new report "Biochips and Microarrays - Technologies, Markets and Companies" to their offering. This ...